山东医药
山東醫藥
산동의약
SHANDONG MEDICAL JOURNAL
2014年
10期
21-24
,共4页
罗来邦%徐志丹%丁利民%罗文峰%龙成美%张友福%李新长
囉來邦%徐誌丹%丁利民%囉文峰%龍成美%張友福%李新長
라래방%서지단%정이민%라문봉%룡성미%장우복%리신장
信号素3F蛋白%肝细胞癌%复发%预后
信號素3F蛋白%肝細胞癌%複髮%預後
신호소3F단백%간세포암%복발%예후
Semaphorin 3F protein%hepatocellular carcinoma%recurrence%prognosis
目的:探讨肝细胞癌(HCC)组织中信号素3F(SEMA3F)蛋白表达与患者预后的关系。方法采用Western blot法检测32例HCC患者手术切除的HCC组织( HCC组)和相应癌旁肝组织(对照组)标本中的SEMA3F蛋白表达,分析SEMA3F蛋白表达水平与HCC临床病理特征、复发转移及预后的关系。结果 HCC组及对照组SEMA3F蛋白表达阳性率分别为84%、97%,HCC组SEMA3F蛋白表达量低于对照组(P<0.05)。肿瘤有包膜者SEMA3F蛋白表达量高于无包膜者,肿瘤为单个结节者表达量高于多个结节者(P均<0.05)。 HCC组有、无肝硬化者的SEMA3F蛋白表达量差异无统计学意义。15例SEMA3F蛋白低表达者复发率显著高于17例高表达者,生存时间短于高表达者(P均<0.05)。结论 SEMA3F可能在抑制HCC的侵袭转移中起重要作用。癌组织中SE-MA3F表达水平有助于判断HCC患者的预后。
目的:探討肝細胞癌(HCC)組織中信號素3F(SEMA3F)蛋白錶達與患者預後的關繫。方法採用Western blot法檢測32例HCC患者手術切除的HCC組織( HCC組)和相應癌徬肝組織(對照組)標本中的SEMA3F蛋白錶達,分析SEMA3F蛋白錶達水平與HCC臨床病理特徵、複髮轉移及預後的關繫。結果 HCC組及對照組SEMA3F蛋白錶達暘性率分彆為84%、97%,HCC組SEMA3F蛋白錶達量低于對照組(P<0.05)。腫瘤有包膜者SEMA3F蛋白錶達量高于無包膜者,腫瘤為單箇結節者錶達量高于多箇結節者(P均<0.05)。 HCC組有、無肝硬化者的SEMA3F蛋白錶達量差異無統計學意義。15例SEMA3F蛋白低錶達者複髮率顯著高于17例高錶達者,生存時間短于高錶達者(P均<0.05)。結論 SEMA3F可能在抑製HCC的侵襲轉移中起重要作用。癌組織中SE-MA3F錶達水平有助于判斷HCC患者的預後。
목적:탐토간세포암(HCC)조직중신호소3F(SEMA3F)단백표체여환자예후적관계。방법채용Western blot법검측32례HCC환자수술절제적HCC조직( HCC조)화상응암방간조직(대조조)표본중적SEMA3F단백표체,분석SEMA3F단백표체수평여HCC림상병리특정、복발전이급예후적관계。결과 HCC조급대조조SEMA3F단백표체양성솔분별위84%、97%,HCC조SEMA3F단백표체량저우대조조(P<0.05)。종류유포막자SEMA3F단백표체량고우무포막자,종류위단개결절자표체량고우다개결절자(P균<0.05)。 HCC조유、무간경화자적SEMA3F단백표체량차이무통계학의의。15례SEMA3F단백저표체자복발솔현저고우17례고표체자,생존시간단우고표체자(P균<0.05)。결론 SEMA3F가능재억제HCC적침습전이중기중요작용。암조직중SE-MA3F표체수평유조우판단HCC환자적예후。
Objective To investigate the expression changes of Semaphorin 3F ( SEMA3F) protein in hepatocellular carcinoma ( HCC) and its relationship with the clinical prognosis .Methods Western blotting was carried out in 32 cases of HCC samples surgically dissected to detect the expression of SEMA 3F protein in both HCC tissues ( HCC group) and pericarcinomatous liver tissues (control group).Tthe relationship between the SEMA3F protein expression changes and clinicopathological features , recurrence/metastasis and clinical prognosis of HCC was analyzed .Results The SEMA3F positive expression rates in the HCC and control groups were 84% and 97%, respectively (P>0.05).Western blotting showed that expression level of SEMA3F in HCC group was lower than that in the control group (P<0.05).The expres-sion level of SEMA3F in tumor-capsulation was higher than that of tumor-without capsulation, and the expression level of SEMA3F in tumor-single nodular was higher than tumor-multiple nodular (all P<0.05).The expression level of SEMA3F between patients with liver cirrhosis and patients without liver cirrhosis in the HCC group had on significant difference ( P>0.05).The recurrence/metastatic rate of 15 cases of low expression was higher than that of 17 cases of high expression and the survival time was shorter than that of the high low expression group (all P<0.05).Conclusion SEMA3F may play an important role in the inhibition of invasion and metastasis of HCC and the expression level of SEMA 3F is helpful to judge the prognosis of patients with HCC .